163 related articles for article (PubMed ID: 15559526)
1. [Slime fight in the lay media. Were the Vioxx fatal cases kept secret?].
Zierenberg O
MMW Fortschr Med; 2004 Oct; 146(43):60. PubMed ID: 15559526
[No Abstract] [Full Text] [Related]
2. [Overestimated].
Höer A; Häussler B
Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
[No Abstract] [Full Text] [Related]
3. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
Bijlsma JW
Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407
[TBL] [Abstract][Full Text] [Related]
4. [Prof. Bernd Simon on nonsteroidal anti-inflammatory drugs. Gastrointestinal complications are unpredictable].
Simon B
MMW Fortschr Med; 2001 May; 143(18):51-2. PubMed ID: 11387712
[No Abstract] [Full Text] [Related]
5. Cyclooxygenase-2 inhibitors and cardiovascular risk.
Smith ER
Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
[No Abstract] [Full Text] [Related]
6. Life after Vioxx: the clinical implications.
Fortun PJ; Hawkey CJ
Hosp Med; 2005 May; 66(5):264-7. PubMed ID: 15920854
[No Abstract] [Full Text] [Related]
7. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
8. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
Messerli FH; Sichrovsky T
Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
[No Abstract] [Full Text] [Related]
9. The lessons of Vioxx.
Frazier KC
N Engl J Med; 2005 Sep; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497
[No Abstract] [Full Text] [Related]
10. Discontinuation of Vioxx.
Nyberg J
Lancet; 2005 Jan 1-7; 365(9453):24-5; author reply 26-7. PubMed ID: 15639670
[No Abstract] [Full Text] [Related]
11. [Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall].
Meyer CH
Klin Monbl Augenheilkd; 2005 Jan; 222(1):62-3. PubMed ID: 15678404
[No Abstract] [Full Text] [Related]
12. The Vioxx debacle.
Alpert JS
Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713
[No Abstract] [Full Text] [Related]
13. Was Vioxx really that dangerous?
Park A
Time; 2005 Feb; 165(9):52. PubMed ID: 15765852
[No Abstract] [Full Text] [Related]
14. Discontinuation of Vioxx.
Boers M
Lancet; 2005 Jan 1-7; 365(9453):25-6; author reply 26-7. PubMed ID: 15639672
[No Abstract] [Full Text] [Related]
15. The Vioxx debacle revisited.
Mohapatra PR; Janmeja AK
Am J Med; 2005 Sep; 118(9):1058. PubMed ID: 16164909
[No Abstract] [Full Text] [Related]
16. [Really only Vioxx?].
Heinzl S
Med Monatsschr Pharm; 2004 Nov; 27(11):361. PubMed ID: 15566229
[No Abstract] [Full Text] [Related]
17. Discontinuation of Vioxx.
McLean TR
Lancet; 2005 Jan 1-7; 365(9453):25; author reply 27-8. PubMed ID: 15639673
[No Abstract] [Full Text] [Related]
18. Discontinuation of Vioxx.
Nutt DJ
Lancet; 2005 Jan 1-7; 365(9453):28. PubMed ID: 15639676
[No Abstract] [Full Text] [Related]
19. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
Harv Heart Lett; 2006 Oct; 17(2):1-3. PubMed ID: 17153752
[No Abstract] [Full Text] [Related]
20. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
Einecke D
MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
